Civilization Ventures is a venture capital firm focused on cutting edge innovations in exponential health tech and biology.
Business Model:
Revenue: $3.3M
Employees: 51-200
Address: 500 Sansome Street
City: San Francisco
State: CA
Zip: 94111
Country: US
Civilization Ventures invests in visionary founders that are leading the future of health tech and biology-driven innovation. We aim to be the first check and lead investor in highly disruptive companies across digital health, synthetic biology, diagnostics, 3D (bio) printing, and AI/ software-enabled health tech. Our team comprises serial entrepreneurs and industry thought leaders who work tirelessly to help each of our portfolio companies succeed.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2021 | Ulab Systems | Series E | 54.5M |
7/2021 | Axonis Therapeutics, Inc. | Venture Round | 0 |
5/2018 | Ulab Systems | Series B | - |
4/2021 | Catena Biosciences | Pre Seed Round | 700k |
6/2021 | Foresight Diagnostics | Series A | 12.5M |
11/2020 | Kit | Seed Round | - |
10/2021 | Teiko.bio | Series A | 11.6M |
11/2018 | Qulab | Seed Round | - |
2/2023 | evonetix | Series B | 0 |
5/2017 | Lemonaid Health | Series A | 0 |
1/2020 | Fluent BioSciences | Series A | 0 |
4/2023 | Foresight Diagnostics | Series B | 0 |
3/2020 | evonetix | Series B | 30M |
7/2017 | Manus Bio | Venture Round | - |
3/2021 | Outpace Bio | Series A | 30M |
6/2019 | Omada Health | Series D | 73M |
9/2017 | Prellis Biologics | Seed Round | 0 |
6/2017 | Omada Health | Series C | 50M |
9/2020 | R-Zero | Series A | 0 |
5/2019 | Pillo Health | Series A | 0 |
1/2018 | evonetix | Series A | 12.3M |
2/2023 | Wyndly | Seed Round | 0 |
3/2020 | BillionToOne | Series A | 15M |
3/2022 | BillionToOne | Series C | 0 |
5/2023 | Siren Biotechnology | Seed Round | - |
5/2019 | Wild Earth | Series A | 11M |
7/2017 | Catalog | Seed Round | 5M |
3/2023 | Outpace Bio | Series A | 0 |
12/2022 | Infinimmune | Seed Round | 0 |
3/2019 | BillionToOne | Series A | 15M |
5/2018 | Shield Bio | Series A | 0 |
9/2021 | OxCan | Seed Round | 0 |
7/2022 | Kernal Biologics | Series A | 0 |
4/2021 | adyn | Seed Round | 2.5M |
10/2017 | Singular Bio | Seed Round | - |
2/2017 | Multerra Bio | Seed Round | - |
6/2019 | Gali Health | Seed Round | 0 |
2/2017 | Pillo Health | Seed Round | 1.5M |
9/2017 | Ulab Systems | Seed Round | 4.9M |
2/2022 | Omada Health | Series E | 0 |
12/2021 | DermBiont | Series A | 0 |
2/2017 | Rocket Pharmaceuticals | Post-IPO Equity | - |
11/2021 | Klivo | Series A | 8.1M |
6/2019 | DermBiont | Series A | 0 |
7/2021 | Glyphic Biotechnologies | Seed | 6M |
5/2018 | Curai Health | Series A | 10.7M |
1/2018 | Alveo Technologies | Series A | 0 |
7/2022 | Kernal Biologics | Series A | 0 |
3/2022 | BillionToOne | Series C | 0 |
2/2022 | Omada Health | Series E | 0 |
12/2021 | DermBiont | Series A | 0 |
11/2021 | Klivo | Series A | 0 |
10/2021 | Teiko.bio | Series A | 0 |
9/2021 | OxCan | Seed Round | 0 |
7/2021 | Axonis | Venture Round | 0 |
7/2021 | Glyphic Biotechnologies | Seed Round | 0 |
6/2021 | Foresight Diagnostics | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|